Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study

Detalles Bibliográficos
Autores principales: Pennington, Becky, Alshreef, Abualbishr, Flight, Laura, Metry, Andrew, Poku, Edith, Hykin, Philip, Sivaprasad, Sobha, Prevost, A. Toby, Vasconcelos, Joana C., Murphy, Caroline, Kelly, Joanna, Yang, Yit, Lotery, Andrew, Williams, Michael, Brazier, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352804/
https://www.ncbi.nlm.nih.gov/pubmed/34148190
http://dx.doi.org/10.1007/s40273-021-01057-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352804/
https://www.ncbi.nlm.nih.gov/pubmed/34148190
http://dx.doi.org/10.1007/s40273-021-01057-y

Ejemplares similares